August 21, 2017 1:18 AM ET

Biotechnology

Company Overview of Lexicon Pharmaceuticals, Inc.

Executive Profile

Praveen Tyle Ph.D.

Executive Vice President of Research and Development, Lexicon Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 9 different industries.

See Board Relationships
57$1,430,282
As of Fiscal Year 2016

Background

Dr. Praveen Tyle, Ph.D. has been Executive Vice President of Research and Development at Lexicon Pharmaceuticals, Inc. since May 16, 2016. Dr. Tyle serves as Member of Executive Board at Rapid Pharmaceuticals AG. He joined Lexicon with more than 30 years of pharmaceutical industry experience of advancing new medical device and drug candidate pipelines to commercial success. He led and completed the successful merger of Vertical Pharmaceuticals and Trigen Laboratories ...

Corporate Headquarters

8800 Technology Forest Place
The Woodlands, Texas 77381

United States

Phone: 281-863-3000
Fax: 281-863-8088

Board Members Memberships

Independent Director
2008-Present
Director

Education

PhD 1984
The Ohio State University
Bachelor's Degree 1980
Institute of Technology, Banaras Hindu University

Other Affiliations

Annual Compensation

Salary$278,509
Bonus$182,500
Total Annual Compensation$461,009

Stocks Options

All Other Compensation$26,373
Unexercisable Options$100,000
Unexercisable Options Value$159,000
Total Value of Options$159,000
Total Number of Options$100,000

Total Compensation

Total Annual Cash Compensation$487,382
Total Short Term Compensation$461,009
Other Long Term Compensation$26,373
Total Calculated Compensation$1,430,282
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Omar S. Ishrak Chairman & CEO
Medtronic plc
$1.5M
Alex Gorsky Chairman & CEO
Johnson & Johnson
$1.6M
Miles D. White Chairman of the Board & CEO
Abbott Laboratories
$1.9M
Timothy M. Ring Chairman and Chief Executive Officer
C. R. Bard, Inc.
$1.1M
Michael F. Mahoney Chairman, Chief Executive Officer and President
Boston Scientific Corporation
$1.0M
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Lexicon Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.